Ribocure Pharmaceuticals Overview
- Year Founded
-
2022
- Status
-
Private
- Employees
-
50
- Latest Deal Type
-
Angel
- Latest Deal Amount
-
$33M
- Investors
-
2
Ribocure Pharmaceuticals General Information
Description
Developer of oligonucleotide therapeutics designed to address the significant medical gaps in rare diseases involved in the fields of cardiovascular, renal and oncology. The company designs and develops drug assets utilizing advanced oligonucleotide technologies and encompasses the entire process from sequence design, screening and optimization to delivery technologies and large-scale commercial CMC capacity, enabling healthcare professionals to conduct research studies of good quality and contribute to bringing new treatments to patients.
Contact Information
Website
www.ribocure.comCorporate Office
- Vetenskapens gränd 11
- Floor 5
- 431 53 Mölndal
- Sweden
Corporate Office
- Vetenskapens gränd 11
- Floor 5
- 431 53 Mölndal
- Sweden
Ribocure Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Angel (individual) | 02-Jul-2025 | $33M | Completed | Generating Revenue | ||
| 1. Angel (individual) | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Ribocure Pharmaceuticals Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Ribocure Pharmaceuticals Patents
Ribocure Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026224266-A2 | Oligonucleotide, oligonucleotide conjugate and composition and use thereof | Pending | 24-Apr-2025 | ||
| WO-2026131490-A1 | Oligonucleotide, oligonucleotide conjugate and composition, and use thereof | Pending | 20-Dec-2024 | ||
| WO-2026109696-A1 | Oligonucleotide, oligonucleotide conjugate and composition and use thereof | Pending | 22-Nov-2024 | ||
| WO-2026109697-A1 | Oligonucleotide, oligonucleotide conjugate and composition and use thereof | Pending | 22-Nov-2024 | ||
| WO-2026057066-A1 | Oligonucleotide, oligonucleotide conjugate, composition, and use | Pending | 14-Sep-2024 |
Ribocure Pharmaceuticals Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Ribocure Pharmaceuticals Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Angel (individual) | Minority | |||
| Angel (individual) | Minority |
Ribocure Pharmaceuticals FAQs
-
When was Ribocure Pharmaceuticals founded?
Ribocure Pharmaceuticals was founded in 2022.
-
Where is Ribocure Pharmaceuticals headquartered?
Ribocure Pharmaceuticals is headquartered in Mölndal, Sweden.
-
What is the size of Ribocure Pharmaceuticals?
Ribocure Pharmaceuticals has 50 total employees.
-
What industry is Ribocure Pharmaceuticals in?
Ribocure Pharmaceuticals’s primary industry is Drug Discovery.
-
Is Ribocure Pharmaceuticals a private or public company?
Ribocure Pharmaceuticals is a Private company.
-
What is the current valuation of Ribocure Pharmaceuticals?
The current valuation of Ribocure Pharmaceuticals is .
-
What is Ribocure Pharmaceuticals’s current revenue?
The current revenue for Ribocure Pharmaceuticals is .
-
How much funding has Ribocure Pharmaceuticals raised over time?
Ribocure Pharmaceuticals has raised $33M.
-
Who are Ribocure Pharmaceuticals’s investors?
and have invested in Ribocure Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
